Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003471552 | SCV004191393 | likely pathogenic | Finnish congenital nephrotic syndrome | 2024-03-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003575105 | SCV004368992 | pathogenic | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 206 of the NPHS1 protein (p.Pro206Thr). This variant is present in population databases (rs201822740, gnomAD 0.05%). This missense change has been observed in individuals with nephrotic syndrome (PMID: 31328266, 34859019). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPHS1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV003575105 | SCV005079320 | uncertain significance | not provided | 2023-08-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31216994, 34859019, 31328266) |